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Abstract
Background: The aetiology of bone cancers is poorly understood. This study examined geographical patterning in
incidence of primary bone cancers diagnosed in 0–49 year olds in Great Britain during 1980–2005 to provide
information on factors linked with disease development. We investigated putative associations with deprivation and
population density.
Methods: Data on osteosarcoma and Ewing sarcoma were obtained from national population-based registries.
Negative binomial regression was used to examine the relationship between incidence rates and the Townsend
deprivation score (and its component variables) and small-area population density.
Results: The study analyzed 2566 osteosarcoma and 1650 Ewing sarcoma cases. For females with osteosarcoma,
statistically significant decreased risk was associated with higher levels of deprivation (relative risk [RR] per unit
increase in deprivation score = 0.969; 95% confidence interval [CI] 0.946–0.993). For all Ewing sarcoma combined,
statistically significant decreased risk was associated with greater area-level population density and higher levels of
non-car ownership (RR per person per hectare increase = 0.984; 95% CI 0.976–0.993, RR per 1% increase in non-car
ownership = 0.994; 95% CI 0.991–0.998).
Conclusions: Higher incidence of osteosarcoma was observed for females in areas with lower deprivation levels
indicating increased risk is linked to some aspect of affluent living. Higher incidence of Ewing sarcoma occurred in
areas of low population density and where more people owned cars, both characteristic of rural environments. The
study adds substantially to evidence associating Ewing sarcoma risk with rural environmental exposures. Putative
risk factors include agricultural exposures, such as pesticides and zoonotic agents.
Background
The exact aetiology of bone cancer is poorly understood.
In the UK, at all ages, the age-standardized rate (to the
world population) is 8 per 1,000,000 persons per year for
males and 6 per 1,000,000 persons per year for females
[1,2]. Bone tumours include more than twenty diagnostic
sub-groups and are the third most common cancer diag-
nosed in 10–24 year olds. The most common sub-group
is osteosarcoma which encompasses more than one third
of all bone cancers. Osteosarcoma reaches a first promin-
ent incidence peak in late childhood or adolescence
around the time of the pubertal growth spurt and then
declines. There is a secondary peak in adults aged more
than 65 years. Ewing sarcoma peaks in incidence in the
late adolescent years [3-6].
A small number of studies have explored geographical
patterning in the incidence of bone cancers. These have
been focused on paediatric cases, aged 0–14 years [7,8].
One recent analysis of childhood incidence data (aged
0–14 years) from the whole of Great Britain (GB) has
found space-time clustering amongst cases of osteosar-
coma, but not Ewing sarcoma. Furthermore, space-time
clustering was statistically significant for female cases of
osteosarcoma, but not for male cases [7]. This was inter-
preted as providing support for the involvement of a
geographically heterogeneous and intermittent environ-
mental exposure in the aetiology of osteosarcoma. An-
other analysis of the same GB data set found increased
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risk of childhood Ewing sarcoma in areas of greater
socio-economic affluence [8].
A recent review of the literature on childhood bone
cancer (specifically osteosarcoma and Ewing sarcoma)
has found that several environmental associations were
reported consistently. This included an association be-
tween parental farming and residence on a farm and
higher risk of all bone cancers, especially Ewing sarcoma
[9]. Geographical or socio-demographic variation in risk
is especially indicative of an environmental component
to aetiology, which may also be associated with gene en-
vironment interactions.
In light of these previous findings, the aim of the
present study was to test predictions of spatial variation
occurring among osteosarcoma and Ewing sarcoma that
might arise as a result of environmental mechanisms
related to area-level population density and area-level
socio-economic deprivation. The following aetiological
hypotheses were tested: a primary factor influencing
geographical heterogeneity of incidence of osteosarcoma
or Ewing sarcoma is modulated by differences between
environmental exposures occurring in (i) less and more
densely populated areas of residence; (ii) less and more
socio-economically deprived areas of residence; and geo-
graphical heterogeneity of incidence of osteosarcoma or
Ewing sarcoma is modulated by (iii) age; and (iv) gender.
The analyses extend the upper bound of the age range
covered by the previous childhood analyses from 15 to
50 years, thus including the peak ages for occurrence of
osteosarcoma and Ewing sarcoma.
Methods
Study subjects
Data were included for all patients who were diagnosed
with primary osteosarcoma or Ewing sarcoma in the
whole of GB (England, Scotland and Wales) during the
period 1st January 1980 to 31st December 2005 and who
were aged less than fifty years at the time of diagnosis.
Cases were limited to this age range because the inci-
dence of Ewing sarcoma is extremely low for cases above
the age of fifty years [1,3] and the second peak of osteo-
sarcoma in the older age group has other possible aetiol-
ogies, including as secondary to Paget’s disease and
radiotherapy [4,10]. General cancer registration in GB is
conducted by eight regional registries in England and by
separate Scottish and Welsh registries. Most of the regis-
tries get their principal information from hospitals’ pa-
tient administration systems (usually electronically) and
pathology laboratories. Some of the registries also use
hospital records staff to collect data, while others employ
peripatetic clerks who visit hospitals. In addition, regis-
tries regularly receive notifications of deaths from the
Office for National Statistics where cancer is mentioned
on the death certificate. Registries match these against
their records to indicate possible cases not already
known to them, or to update details of existing records.
The final datasets of all incident cases of cancer are
thereby constructed.
After gaining all necessary regulatory and ethical
approvals (UK National Research Ethics Service, Sunder-
land Research Ethics Committee reference number 09/
H0904/5) West Midlands Cancer Intelligence Unit
(WMCIU) coordinated the request for data from all re-
gional cancer registries in England and Wales. A separ-
ate request was made to the Information Services
Division for Scotland in order for data to be released
from the Scottish Cancer Registry.
Case data for children, aged 0–14 years, were also
extracted from the National Registry of Childhood
Tumours (NRCT). The NRCT is a population-based
registry covering the whole of GB [11]. It includes
records for nearly all children, aged 0–14 years, diag-
nosed with cancer from 1962 to the present day. This
data set was used to cross-check the accuracy of the case
counts for childhood data from the regional registries.
Diagnostic groups
Cases were classified into diagnostic groups according to
the International Classification of Diseases for Oncology,
third edition (ICD-O-3) [12]. All diagnoses were coded
to ICD-O-3 using information on pathology (morph-
ology and topography). The following diagnostic groups
were specified a priori for analysis: (i) osteosarcoma
(ICD-O-3 topography codes for sites classified as bones
and joint: C400-C403, C408-C414, C418-419 and asso-
ciated morphology codes 9180/3; 9181/3, 9182/3, 9183/
3, 9184/3, 9185/3, 9186/3, 9187/3, 9192/3, 9193/3, 9194/
3, 9195/3) and (ii) Ewing sarcoma (ICD-O-3 topography
codes for sites classified as bones and joint: C400-C403,
C408-C414; C418-C419, C760-C768 and associated
morphology code 9260/3; 9261/3).
Population data
For England and Wales, the sub-national hierarchy of
geographies, for which population data are available, is
as follows (largest to smallest): government office region
(0–49 population ranges from 1,660,000 to 5,600,000,
median = 3,430,000); local authority district (0–49 popu-
lation ranges from 1,200 to 720,900, median = 72,600);
and census ward (0–49 population ranges from 297 to
29,300, median = 3,090). In Scotland, postcode sectors
are equivalent to census wards (0–49 population ranges
from 23 to 15,916, median = 3,201). In this study, ana-
lyses were performed at the small-area census ward level
in England and Wales and postcode sector level in
Scotland. During the study period, there were three cen-
suses in the whole of GB [13-15]. There were also wide-
spread boundary changes throughout this time span,
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especially at small-area level. To allow for these pertur-
bations, Norman’s method was used to derive population
estimates using the small-area boundaries that pertained
at the time of the 2001 census [16].
Demographic data
Small-area (census ward in England and Wales and post-
code sector in Scotland) demographic characteristics
were derived from the censuses [17-19]. These character-
istics were population density (persons per hectare) and
level of deprivation. The Townsend score for deprivation
at the small-area level (and not individual level) was cal-
culated [20]. This is a combination of four census mea-
sures: unemployment, household with no car, non-home
ownership and household overcrowding. A time series of
Townsend deprivation scores was constructed by appor-
tioning these four constituent measures from the 1981,
1991 and 2001 censuses (applied to 1980–1985, 1986–
1995 and 1996–2005 data, respectively) to the 2001 cen-
sus geography [21]. Increasingly negative Townsend
scores represent lower area deprivation. Increasingly
positive scores represent higher deprivation. Population
density was apportioned in a similar way.
Statistical methods
Age-specific incidence rates per million persons per year
were calculated based on annual mid-year population
estimates for the study region obtained from the Office
for National Statistics (ONS). Comparisons of age-
standardized incidence rates (ASRs) are only meaningful
if they are standardized in a similar fashion. ASRs were
calculated using the standard world population (origin-
ally proposed by Segi, but modified by Doll and collea-
gues and constructed from the pooled populations of
forty-six representative countries that had accurate
population data) [2,22-24]. Temporal trends were
assessed using Poisson regression. An assumption of a
linear trend was tested by inclusion of a non-linear (cat-
egorical) term for year in the model. The interaction be-
tween gender and time was also analyzed.
For the ecological analysis, there was evidence of
extra-Poisson variation: for osteosarcoma 98.5% of age
group and gender specific small-area (wards or postcode
sectors) cells had zero counts and for Ewing sarcoma
99.1% of age group and gender specific small-area
(wards or postcode sectors) cells had zero counts.
Therefore, the incidence of osteosarcoma and Ewing sar-
coma was modelled at the census small-area level using
negative binomial regression in STATA [25]. The num-
ber of cases observed in each small-area was the
dependent variable and the logarithm of the underlying
population was used as the offset. The ecological (inde-
pendent) variables were the census-derived small-area
characteristics, which were allocated to the 2001 census
geography using Norman’s method [21].
A series of multivariable models were fitted including
the following independent variables: gender, age (categor-
ized in three groups as: 0–14, 15–29 and 30–49 years),
population density, Townsend score (as a composite).
The following components of the Townsend score were
included in separate models that did not include the
composite score: percentage of overcrowded houses, per-
centage of households without a car, percentage of
households with residents unemployed and percentage of
homes that are not owner occupied. Interactions between
age and gender (age*gender), region and gender (region*-
gender) and the Townsend deprivation score and gender
(Townsend*gender) were also considered for inclusion in
the models. Each variable in turn was removed and com-
pared using a likelihood ratio test. Thus, the effect of
each variable was assessed by calculating differences in
residual deviances and comparing with a chi-square dis-
tribution with degrees of freedom (df) equal to the differ-
ence in residual degrees of freedom. Model fit was
assessed using both the residual deviance and the Akaike
information criterion (AIC). Linearity assumptions were
tested by including quintiles of significant continuous
variables as ordinal variables in the models.
Significant effects are reported as relative risks (RRs)
and associated 95% confidence intervals (CIs). All P
values were two-sided and statistical significance was
taken as P< 0.05 throughout the analyses.
Results
Osteosarcoma
There were a total of 2566 patients aged 0–49 years
(1493 males and 1073 females) diagnosed with osteosar-
coma in GB between 1980 and 2005. The ASR over the
study period was 2.64 per million persons per year (95%
CI 2.53 to 2.74) for all 0–49 year olds. For males and
females, the overall ASRs were 3.00 (95% CI 2.85 to
3.16) and 2.27 (95% CI 2.13 to 2.41) per million persons
per year, respectively. Case numbers, crude rates and
ASRs by age-group, period, region and gender are given
in Table 1. An assumption of a linear trend was con-
firmed to be valid and Poisson regression showed that
there was a significant annual increase in the incidence
of osteosarcoma of 1.0% (95% CI 0.5 to 1.5) over the
study period. The ratio of the ASRs for males: females
was 1.3 (95% CI 1.2 to 1.4) and this remained constant
over the study period (P= 0.415).
The analyses of deviance and AIC showed that model fit
for osteosarcoma was significantly improved for both
gender (P< 0.0001) and age (P< 0.0001) and that there
was a significant interaction between gender and age
(P< 0.0001), with lower female rates overall, but higher
rates in females aged 0–14 years. There was, however,
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Table 1 Rates of Osteosarcoma in GB by age, period, region and gender during 1980-2005
N Pop
(000’s)
All
Crude Rate / million
ASR (95% CI) N Pop
(000’s)
Male
Crude Rate / million
ASR (95% CI) N Pop
(000’s)
Female
Crude Rate / million
ASR (95 % CI) ASR Ratio M:F
(95% CI)
Age
Ages 0 to 14 817 279909 2.92 2.78 (2.59,2.97) 406 142623 2.85 2.70 (2.44,2.97) 411 137286 2.99 2.86 (2.58,3.14) 0.9 (0.8,1.1)
Ages 15 to 29 1315 311514 4.22 3.97 (3.76,4.19) 821 156621 5.24 4.95 (4.61,5.29) 494 154894 3.19 2.98 (2.71,3.24) 1.7 (1.5,1.9)
Ages 30 to 49 434 400790 1.08 1.08 (0.97,1.18) 266 199591 1.33 1.33 (1.17,1.49) 168 201199 0.83 0.83 (0.70,0.95) 1.6 (1.3,1.9)
Period
1980 - 1985 524 225881 2.32 2.15 (1.96,2.34) 304 113741 2.67 2.44 (2.17,2.72) 220 112140 1.96 1.85 (1.60,2.10) 1.3 (1.1,1.6)
1986 - 1995 1010 382985 2.64 2.74 (2.57,2.91) 607 192375 3.16 3.21 (2.95,3.47) 403 190609 2.11 2.26 (2.04,2.49) 1.4 (1.2,1.6)
1996 - 2005 1032 383347 2.69 2.84 (2.67,3.02) 582 192718 3.02 3.15 (2.89,3.41) 450 190629 2.36 2.53 (2.29,2.77) 1.2 (1.1,1.4)
Region
North East 123 45292 2.72 2.75 (2.25,3.24) 73 22711 3.21 3.18 (2.44,3.92) 50 22581 2.21 2.31 (1.66,2.96) 1.4 (0.9,1.9)
North West 278 120449 2.31 2.31 (2.03,2.58) 168 60464 2.78 2.73 (2.32,3.15) 110 59985 1.83 1.88 (1.53,2.24) 1.5 (1.1,1.8)
Yorkshire & Humber 236 87272 2.70 2.71 (2.36,3.06) 147 43870 3.35 3.32 (2.78,3.86) 89 43403 2.05 2.09 (1.65,2.53) 1.6 (1.2,2.0)
East Midlands 193 71476 2.70 2.74 (2.34,3.13) 100 36038 2.77 2.78 (2.23,3.33) 93 35438 2.62 2.69 (2.13,3.25) 1.0 (0.7,1.3)
West Midlands 238 93160 2.55 2.59 (2.25,2.92) 128 46964 2.73 2.68 (2.21,3.15) 110 46196 2.38 2.49 (2.02,2.96) 1.1 (0.8,1.4)
East of England 233 91147 2.56 2.64 (2.30,2.99) 129 45929 2.81 2.87 (2.37,3.37) 104 45218 2.30 2.41 (1.94,2.88) 1.2 (0.9,1.5)
London 341 129437 2.63 2.88 (2.56,3.20) 200 64819 3.09 3.31 (2.83,3.78) 141 64618 2.18 2.46 (2.04,2.88) 1.3 (1.0,1.6)
South East 353 135307 2.61 2.67 (2.39,2.95) 197 68226 2.89 2.91 (2.50,3.32) 156 67081 2.33 2.42 (2.04,2.81) 1.2 (0.9,1.5)
South West 198 79244 2.50 2.52 (2.16,2.87) 115 39917 2.88 2.83 (2.30,3.35) 83 39327 2.11 2.20 (1.72,2.69) 1.3 (0.9,1.7)
Wales 119 49236 2.42 2.37 (1.94,2.80) 77 24700 3.12 3.01 (2.33,3.69) 42 24536 1.71 1.72 (1.19,2.25) 1.7 (1.1,2.4)
Scotland 228 90201 2.53 2.55 (2.22,2.89) 144 45202 3.19 3.19 (2.66,3.72) 84 44999 1.87 1.90 (1.48,2.31) 1.7 (1.2,2.1)
Total 1 2566 992213 2.59 2.64 (2.53,2.74) 1493 498835 2.99 3.00 (2.85,3.16) 1073 493379 2.17 2.27 (2.13,2.41) 1.3 (1.2,1.4)
1Includes 26 cases with unknown region.
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no significant variation in incidence between geographical
regions (P=0.8346), nor was there any interaction be-
tween gender and region (P=0.334). Townsend score (as
a composite), and then in separate models with all four of
its component variables, were statistically significant (for
overall Townsend score: P< 0.0001) compared with the
model containing age, gender and age*gender. Further-
more, there was a statistically significant interaction be-
tween Townsend score and gender (P=0.0102).
Population density was associated with a statistically sig-
nificant improvement in model fit (P=0.0001) compared
with the model containing age, gender and age*gender,
but was not significant when compared with the model
containing age, gender, age*gender and Townsend score
(P=0.1388). The best fitting model contained: gender, age,
the interaction gender*age, the Townsend score and the
interaction Townsend*gender. Table 2 gives a comparison
of the goodness-of-fit of the different models, assessed
using residual deviance and AIC with model 17 denoting
the best-fitting model. An assumption of a linear trend for
the Townsend score was confirmed (P< 0.001).
Table 3 gives the RRs for the best fitting model con-
taining gender, age, the interaction gender*age, the
Townsend score and the interaction Townsend*gender.
This shows that the protective effect of increased levels
of deprivation is greater for females than for males. For
females, a statistically significant decreased risk was
associated with higher Townsend score (i.e. more
deprived, RR for one unit increase in the deprivation
score = 0.969; 95% CI 0.946 to 0.993).
Ewing sarcoma
There were a total of 1650 patients aged 0–49 years (988
males and 662 females) diagnosed with Ewing sarcoma
in GB between 1980 and 2005. The ASR over the study
period was 1.76 per million persons per year (95% CI
1.67 to 1.84) for all 0–49 year olds. For males and
females, the overall ASRs were 2.06 (95% CI 1.92 to
2.19) and 1.45 (95% CI 1.34 to 1.56) per million persons
per year, respectively. Case numbers, crude rates and
ASRs by age-group, period, region and gender are given
in Table 4. Poisson regression showed a significant an-
nual increase in the incidence of Ewing sarcoma of 1.2%
(95% CI 0.6-1.9) over the study period. The ratio of the
ASRs for males: females was 1.4 (95% CI 1.3 to 1.6) and
this remained constant over the study period (P= 0.123).
The analyses of deviance and AIC show that incidence
of Ewing sarcoma was associated with both gender
(P< 0.0001) and age (P< 0.0001). There was also an
interaction between gender and age (P< 0.0001), with
lower female rates overall, but higher rates in females aged
0–14 years. Incidence varied by region (P< 0.0001).
However, further improvement to model fit (AIC) was
provided by inclusion of covariates for both East
Midlands and Scotland in the model (Table 5, model 7).
Incidence was higher in the East Midlands (RR = 1.207;
95% CI 1.012 to 1.440; P = 0.0356) and Scotland
(RR=1.428; 95% CI 1.221 to 1.671; P< 0.001) (Table 5).
However, there was no interaction between gender and
region (P=0.621).
Population density was statistically significant (P< 0.0001),
compared with the model containing gender, age, the
interaction gender*age, East Midlands and Scotland.
Townsend score (as a composite) and then in separ-
ate models with all of its components (non-car
Table 2 Hierarchical series of models for Osteosarcoma
with goodness of fit diagnostics
Model Factors/interactions df1 deviance AIC2
0 Null 175672 18788.0 25587.9
1 Gender 175671 18728.0 25529.9
2 Age 175670 18074.1 24878.0
3 Age & Gender 175669 18017.2 24823.1
4 Age, Gender*Age 175668 17976.3 24784.2
5 Age, Gender*Age & Region 175658 17970.6 24798.5
6 Age, Gender*Age & Population density 175667 17961.4 24771.3
7 Age, Gender*Age & Townsend 175667 17947.5 24757.4
8 Age, Gender*Age & Overcrowding 175667 17968.4 24778.3
9 Age, Gender*Age & No cars 175667 17951.4 24761.3
10 Age, Gender*Age & Unemployment 175667 17955.9 24765.8
11 Age, Gender*Age & Home ownership 175667 17956.9 24766.8
12 Age, Gender*Age, Townsend
& Population density
175666 17945.3 24757.2
13 Age, Gender*Age, Overcrowding
& Population density
175666 17945.2 24757.1
14 Age, Gender*Age, No cars
& Population density
175666 17947.5 24759.4
15 Age, Gender*Age, Unemployment
& Population density
175666 17947.5 24759.4
16 Age, Gender*Age, Home ownership
& Population density
175666 17947.1 24759.0
17 Age, Gender*Age, Townsend
& Townsend*female
175666 17940.9 24752.8
1df = residual degrees of freedom, 2AIC = Akaike Information Criterion.
Table 3 Effect on Osteosarcoma incidence of gender
(female), age and Townsend deprivation score
Factor/interaction Coefficient (95% CI1) RR2 (95% CI) P value
Female −0.490 (−0.588,-0.391) 0.613 (0.555,0.676) <0.001
Age 15-29 0.648 (0.528,0.768) 1.912 (1.696,2.155) <0.001
Age 30-49 −0.739 (−0.882,-0.597) 0.477 (0.414,0.551) <0.001
Female & age 0-14 0.551 (0.380,0.722) 1.736 (1.463,2.059) <0.001
Townsend −0.019 (−0.035,-0.004) 0.981 (0.966,0.996) 0.015
Female & Townsend −0.032 (−0.056,-0.007) 0.969 (0.946,0.993) 0.010
1CI = Confidence Interval, 2RR = Relative Risk.
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Table 4 Rates of Ewing Sarcoma in GB by age, period, region and gender during 1980-2005
N Pop
(000’s)
All
Crude Rate / million
ASR (95% CI) N Pop
(000’s)
Male
Crude Rate/ million
ASR (95% CI) N Pop
(000’s)
Female
Crude Rate/ million
ASR (95% CI) ASR Ratio
M:F (95% CI)
Age
Ages 0 to 14 659 279909 2.35 2.28 (2.11,2.46) 356 142623 2.50 2.43 (2.17,2.68) 303 137286 2.21 2.13 (1.89,2.37) 1.1 (1.0,1.3)
Ages 15 to 29 800 311514 2.57 2.39 (2.23,2.56) 516 156621 3.29 3.06 (2.79,3.32) 284 154894 1.83 1.71 (1.51,1.92) 1.8 (1.5,2.0)
Ages 30 to 49 191 400790 0.48 0.47 (0.40,0.53) 116 199591 0.58 0.57 (0.47,0.67) 75 201199 0.37 0.36 (0.28,0.45) 1.6 (1.1,2.0)
Period
1980 - 1985 331 225881 1.47 1.46 (1.30,1.62) 186 113741 1.64 1.58 (1.35,1.82) 145 112140 1.29 1.33 (1.11,1.55) 1.2 (0.9,1.5)
1986 - 1995 649 382985 1.69 1.81 (1.67,1.95) 393 192375 2.04 2.16 (1.94,2.37) 256 190609 1.34 1.46 (1.28,1.64) 1.5 (1.2,1.7)
1996 - 2005 670 383347 1.75 1.90 (1.76,2.05) 409 192718 2.12 2.26 (2.04,2.48) 261 190629 1.37 1.53 (1.34,1.72) 1.5 (1.2,1.7)
Region
North East 69 45292 1.52 1.64 (1.25,2.03) 44 22711 1.94 2.08 (1.46,2.70) 25 22581 1.11 1.19 (0.77,1.76) 1.7 (0.9,2.6)
North West 191 120449 1.59 1.61 (1.38,1.84) 112 60464 1.85 1.86 (1.51,2.21) 79 59985 1.32 1.37 (1.06,1.67) 1.4 (1.0,1.8)
Yorkshire & Humber 152 87272 1.74 1.83 (1.53,2.12) 93 43870 2.12 2.18 (1.73,2.63) 59 43403 1.36 1.47 (1.09,1.85) 1.5 (1.0,2.0)
East Midlands 140 71476 1.96 2.02 (1.68,2.36) 68 36038 1.89 1.90 (1.44,2.36) 72 35438 2.03 2.14 (1.64,2.64) 0.9 (0.6,1.2)
West Midlands 130 93160 1.40 1.45 (1.20,1.70) 77 46964 1.64 1.70 (1.32,2.09) 53 46196 1.15 1.19 (0.86,1.52) 1.4 (0.9,1.9)
East of England 141 91147 1.55 1.68 (1.40,1.97) 85 45929 1.85 1.98 (1.55,2.40) 56 45218 1.24 1.39 (1.02,1.75) 1.4 (0.9,1.9)
London 181 129437 1.40 1.58 (1.34,1.81) 114 64819 1.76 1.97 (1.60,2.34) 67 64618 1.04 1.18 (0.88,1.47) 1.7 (1.1,2.2)
South East 212 135307 1.57 1.70 (1.46,1.93) 120 68226 1.76 1.84 (1.50,2.17) 92 67081 1.37 1.55 (1.23,1.87) 1.2 (0.9,1.5)
South West 141 79244 1.78 1.86 (1.55,2.18) 93 39917 2.33 2.39 (1.90,2.89) 48 39327 1.22 1.31 (0.93,1.69) 1.8 (1.2,2.5)
Wales 85 49236 1.73 1.80 (1.41,2.18) 57 24700 2.31 2.35 (1.74,2.97) 28 24536 1.14 1.23 (0.81,1.79) 1.9 (1.0,2.8)
Scotland 197 90201 2.18 2.25 (1.93,2.57) 119 45202 2.63 2.68 (2.19,3.17) 78 44999 1.73 1.81 (1.40,2.22) 1.5 (1.1,1.9)
Total 1 1650 992213 1.66 1.76 (1.67,1.84) 988 498835 1.98 2.06 (1.92,2.19) 662 493379 1.34 1.45 (1.34,1.56) 1.4 (1.3,1.6)
1Includes 11 cases with unknown region.
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ownership, unemployment, housing tenure and house-
hold overcrowding) was statistically significant (for over-
all Townsend score: P< 0.0001), compared with the
model containing gender, age, the interaction gender*-
age, East Midlands and Scotland. Furthermore, Town-
send score (as a composite), and then in separate models
containing two of its components (non-car ownership and
unemployment, but not housing tenure and house-
hold overcrowding) remained statistically significant (for
overall Townsend score: P=0.0181), compared with the
model containing gender, age, gender*age, East Mid-
lands, Scotland and population density. However, the
best fitting model contained: age, gender, age*gender,
East Midlands, Scotland, population density and non-car
ownership. Table 5 gives a comparison of the goodness-of-
fit of the different models, assessed using residual de-
viance and AIC with model 14 denoting the best-fitting
model. Assumptions of linear trends for population
density and non-car ownership were confirmed (P< 0.001
for both variables).
Table 6 gives the RRs for the best fitting model
containing age, gender, age*gender, population density
and non-car ownership. This shows that statistically
significant decreased risk was associated with greater
area-level population density (RR for an increase of one
person per hectare = 0.984 95% CI 0.976 to 0.993) and
was also associated with greater levels of non-car ownership
(RR for an increase of one percent in non-car owner-
ship = 0.994; 95% CI 0.991 to 0.998).
Discussion
This is the first comprehensive small-area analysis of
osteosarcoma and Ewing sarcoma in 0–49 year olds from
GB. Furthermore, it is the largest geographical study of
these tumour types to date. GB is an ideal setting for this
type of investigation due to the availability of highly accur-
ate and complete cancer registration data, together with
corresponding population census data. The study has
revealed two novel findings: (a) for females lower inci-
dence of osteosarcoma was associated with higher levels
of deprivation; (b) lower incidence of Ewing sarcoma was
associated with residence in more densely populated areas
and higher levels of non-car ownership.
Our prior hypotheses were: a primary factor influen-
cing geographical heterogeneity of incidence of osteosar-
coma or Ewing sarcoma is modulated by differences
between environmental exposures occurring in (i) less
and more densely populated areas of residence; (ii) less
and more socio-economically deprived areas of resi-
dence; and geographical heterogeneity of incidence of
osteosarcoma or Ewing sarcoma is modulated by (iii)
age; and (iv) gender.
For osteosarcoma the results suggest that, at least for
females, geographical heterogeneity of incidence is
Table 5 Hierarchical series of models for Ewing Sarcoma
with goodness of fit diagnostics
Model Factors/interactions df1 deviance AIC2
0 Null 175672 13680.3 18089.1
1 Gender 175671 13622.2 18033.0
2 Age 175670 13015.2 17428.0
3 Age & Gender 175669 12960.6 17375.3
4 Age, Gender, Age*Gender 175668 12942.9 17359.7
5 Age, Gender, Age*Gender & Region 175658 12911.1 17347.9
6 Age, Gender, Age*Gender, EM3 175667 12938.4 17357.2
7 Age, Gender, Age*Gender,
Scotland, EM
175666 12921.3 17342.1
8 Age, Gender, Age*Gender, Scotland,
EM & Population density
175665 12883.6 17306.4
9 Age, Gender, Age*Gender, Scotland,
EM & Townsend
175665 12895.5 17318.2
10 Age, Gender, Age*Gender, Scotland,
EM & Overcrowding
175665 12912.1 17334.9
11 Age, Gender, Age*Gender, Scotland,
EM & No cars
175665 12888.6 17311.4
12 Age, Gender, Age*Gender, Scotland,
EM & Unemployment
175665 12904.7 17327.5
13 Age, Gender, Age*Gender, Scotland,
EM & Home ownership
175665 12906.8 17329.6
14 Age, Gender, Age*Gender, Scotland,
EM, Population density & No cars
175664 12875.2 17300.0
15 Age, Gender, Age*Gender, Scotland,
EM, Pop dens & Unemployment
175664 12878.4 17303.2
16 Age, Gender, Age*Gender, Scotland,
EM, Population density & Townsend
175664 12878.0 17302.8
17 Age, Gender, Age*Gender, Scotland,
EM, Pop dens & Overcrowding
175664 12883.4 17308.2
18 Age, Gender, Age*Gender, Scotland,
EM, Pop dens & Home owner
175664 12881.5 17306.3
1df = residual degrees of freedom, 2AIC = Akaike Information Criterion, 3East
Midlands.
Table 6 Effect on Ewing Sarcoma incidence of female
gender, age, East Midlands, Scotland, population density
and non-car ownership
Factor/interaction Coefficient
(95% CI1)
RR2 (95% CI) P value
Female −0.548 (−0.679,-0.417) 0.578 (0.507,0.659) <0.001
Age 15-29 0.316 (0.180,0.452) 1.372 (1.198,1.571) <0.001
Age 30-49 −1.385 (−1.569,-1.201) 0.250 (0.208,0.301) <0.001
Female & age 0-14 0.433 (0.230,0.636) 1.542 (1.259,1.890) <0.001
East Midlands 0.188 (0.012,0.364) 1.207 (1.012,1.440) 0.037
Scotland 0.356 (0.199,0.513) 1.428 (1.221,1.671) <0.001
Pop density
(person / hectare)
−0.016 (−0.025,-0.007) 0.984 (0.976,0.993) <0.001
Non-car ownership (%) −0.006 (−0.009,-0.002) 0.994 (0.991,0.998) 0.004
1CI = Confidence Interval, 2RR = Relative Risk.
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modulated by differences in environmental exposures
occurring in less and more socio-economically deprived
areas of residence (providing support for prior hypoth-
eses (ii) and (iv), but little support for prior hypotheses
(i) and (iii)). For Ewing sarcoma the results suggest that
geographical heterogeneity of incidence is modulated by
differences in environmental exposures occurring in less
and more densely populated areas and that incidence is
also modulated by some aspect of differences between
environmental exposures occurring in less and more
socio-economically deprived areas of residence. How-
ever, some of the components of deprivation may be
confounded with population density apart from non-car
ownership (providing support for prior hypotheses (i)
and (ii)). Comparison of the case counts for both osteo-
sarcoma and Ewing sarcoma from the WMCIU for chil-
dren aged 0–14 years across all regions confirmed
virtually identical agreement with the counts from the
NRCT dataset.
Two methodological caveats should be noted. First of
all, census ward (or postcode sector) population density
and Townsend deprivation scores are not necessarily
related to characteristics of individual cases and should
only be regarded as ecological measurements. Area-level
data have been assigned to individual cases. Care should
be exercised when using such grouped data to make infer-
ences about individuals. There may be unknown con-
founding factors that display the same pattern of spatial
heterogeneity [26]. Secondly, the case, population and
demographic data were analyzed using 2001 census
boundaries. The method did not take into account the
possible effects of migration, which may have diluted the
results. Nevertheless, the findings were very clear cut, in-
dicating that this does not appear to have been a major
limitation.
The study has a number of particular strengths. First, it
analyses high-quality population-based data. Secondly, the
inclusion of ages 0 to 49 years includes the peak incidence
of both osteosarcoma and Ewing sarcoma, which occur in
the teenage years. There is a theoretical possibility that
diagnosis delays vary according to some of the demo-
graphic factors that have been analyzed here. Conse-
quently, a lower maximum age limit might have led to
differential loss of some cases, according to demographics.
Previous studies have explored geographical patterning
in the incidence of bone cancers, but have been focused
on children, aged 0–14 years [7,8]. An analysis of child-
hood incidence data in GB found space-time clustering
amongst cases of osteosarcoma, but not Ewing sarcoma.
The space-time clustering was significant for females, but
not for males [7]. This was interpreted as providing sup-
port for the involvement of a geographically heteroge-
neous and transient environmental exposure in the
aetiology of osteosarcoma. Effects of such an exposure
may be modulated by gender. Another analysis of the
same national GB data set found increased risk of child-
hood Ewing sarcoma in areas of greater socio-economic
affluence [8]. However, the age-specific incidence of these
tumours means that to cut off analyses at age 14 years is
artefactual and an extended age range to cover the major-
ity of the conditions is more appropriate, such as the one
described here. It is possible that the splitting of age–
groups at 0–14 and 15–29 years may have led to a dilution
of the number of male cases in the peak age-range which
straddle both groups and thus have led to the female-
specific effect for deprivation amongst cases of osteosar-
coma. However, a further supplementary analysis used age
groups 0–29 and 30–49 years and found that the inter-
action between deprivation and gender was still present
(data not shown).
The aetiology of osteosarcoma is likely to involve both
genetic predisposition and environmental triggers. How-
ever, known genetic factors only account for a small pro-
portion of cases [9,27-33]. The present study has shown
that increased levels of deprivation (i.e. less affluence)
are protective against osteosarcoma. This suggests that
differences in some aspect of lifestyle may predispose to
greater risk of osteosarcoma. These differences may in-
clude both dietary and social factors. A meta-analysis of
fourteen studies has found that the mean height of
osteosarcoma patients was two to three centimetres
greater than the reference population. The authors
described this finding as a surrogate for affluence. How-
ever, there was no obvious bias towards females [34].
Another pooled analysis (of seven studies) found that
taller than average individuals had increased risk of
osteosarcoma and very tall individuals had even greater
risk [35]. Such differences in height are characteristic of
more affluent living conditions during childhood. A fur-
ther recent descriptive analysis of incident data on cases
of bone cancer, diagnosed in England during the period
1979–2003 showed that the female peak was earlier (10–
14 years) than for males (15–19 years). The authors pro-
posed that pubertal bone growth may be implicated [36].
Our findings suggest that during this period females
may be more vulnerable to a putative environmental
hazard as a consequence of hormonal effects. Another
small case–control study of juvenile bone tumours (in
88 patients aged 8–25 years) found increased risk asso-
ciated with frequent change of residence and previous
mumps [37]. Together with finding of space–time clus-
tering, this suggests that it is possible that one or more
infectious agents may be implicated [7]. The possible as-
sociation with frequent change of residence would sug-
gest that some aspect of population mixing may be
implicated. We would postulate that the pathway is
likely to be indirect. Such a mechanism has been pro-
posed for childhood leukaemia, with unusual population
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mixing or delayed exposure to common infections in
early life conferring greater risk [38]. Further epidemio-
logical studies (e.g. using a case–control design) are
needed to determine if infections occurred more fre-
quently prior to diagnosis in cases of osteosarcoma,
compared with an unaffected control group. The nature
and type of putative infections should also be investi-
gated. However, it should be noted that the rarity of this
condition would make the conducting of a case–control
study relatively expensive.
Both genetic and environmental factors are also impli-
cated in the aetiology of Ewing sarcoma. However, again
genetic factors alone can only explain a small fraction of
the total cases [39,40]. The present study has shown a
higher risk with residential living in less densely popu-
lated areas, but also with higher levels of car ownership.
These are both characteristic of rural areas. Markedly
higher incidence was apparent in East Midlands and
Scotland, which both contain large areas of rural ex-
panse. Rural living, together with high levels of car own-
ership, may also be consistent with a certain type of
socio-economic affluence. Potential exposures that have
been linked with Ewing sarcoma include both pesticides
and zoonotic infectious agents [41-43]. If infectious
agents are involved the mechanism is likely to be differ-
ent from osteosarcoma, as Ewing sarcoma did not ex-
hibit space-time clustering [7]. Further studies should
determine if higher risk of Ewing sarcoma is associated
with residential living in close proximity to areas with
predominantly agricultural land use. Analyses could in-
clude investigating possible associations with land use
data, including types of crop grown and pesticides used.
Conclusions
We have found that lower incidence of osteosarcoma in
females was observed in areas associated with higher levels
of deprivation indicating decreased risk is linked to some
aspect of less affluent living conditions. Lower incidence
of Ewing sarcoma occurred in areas of high population
density and where fewer people owned cars, suggesting
rural area characteristics are linked to increased risk of
this malignancy. The study adds substantially to the grow-
ing body of evidence that associates risk of Ewing sarcoma
with rural environmental exposures. Putative risk factors
include agricultural exposures, such as pesticides and zoo-
notic agents.
Competing interests
The author(s) declare that they have no competing interests.
Authors’ contributions
RJQM, KB, RCP, PWJ, PN, AWC and RGF contributed to the design of the
study, the writing of the manuscript and the analysis and interpretation of
data. BGP, CS, TJV, PAM and MFM contributed to the writing of the
manuscript and the interpretation of data. All authors read and approved the
final manuscript.
Acknowledgements
This work was supported by The Bone Cancer Research Trust (KB) and The
North of England Children’s Cancer Research Fund (NECCR, PWJ, KB). RGF
was supported by grant funding from the National Institute for Health
Research and Children with Leukaemia. We are most grateful to the staff of
the WMCIU (in particular Dr Gill Lawrence and Mrs Sally Vernon who co-
ordinated the data request from cancer registries in England and Wales) and
the Scottish Cancer Registry for facilitating the case data for the analyses. We
are also indebted to Richard Hardy (funded by the NECCR at Institute of
Health and Society, Newcastle University) for providing IT support. The work
is based on census data, which are copyright of The Crown. The work is
based on data provided with the support of the ESRC and JISC and uses
Census boundary material, which is copyright of The Crown and the ED-LINE
Consortium. The funders had no involvement in study design, data
collection, data analysis, manuscript preparation or publication decisions.
Author details
1Institute of Health and Society, Newcastle University, England, UK. 2Centre
for Epidemiology & Biostatistics, University of Leeds, England, UK. 3Childhood
Cancer Research Group, Department of Paediatrics, University of Oxford,
England, UK. 4School of Geography, University of Leeds, England, UK.
5Northern Institute of Cancer Research, Newcastle University, England, UK.
6Institute of Health and Society, Newcastle University, Sir James Spence
Institute, Royal Victoria Infirmary, Queen Victoria Road Newcastle upon Tyne,
NE1 4LP, England, UK.
Received: 28 September 2011 Accepted: 27 June 2012
Published: 27 June 2012
References
1. Office for National Statistics: Cancer statistics registrations: registrations of
cancer diagnosed in 2008, England. Series MB1 no.39. London UK: HMSO;
2010.
2. Smith PG: Comparison between registries: age-standardised rates. In
Cancer Incidence in Five Continents, Volume VI. Edited by Parkin DM, Muir CS,
Whelan SL, Gao YT, Ferlay J, Powell J. Lyon, France: IARC Scientific
Publications; 1992.
3. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P:
Cancer Incidence in Five Continents, IX. Lyon, France: IARC Scientific
Publications; 2007.
4. Ottaviani G, Jaffe N: The epidemiology of osteosarcoma. Canc Treat Res
2009, 152:3–13.
5. Skubitz KM, D’Adamo DR: Sarcoma. Mayo Clin Proc 2007, 82:1409–1432.
6. Weber K, Damron TA, Frassica FJ, Sim FH: Malignant bone tumors. Instr
Course Lect 2008, 57:673–688.
7. McNally RJ, Alexander FE, Bithell JF: Space-time clustering of childhood
cancer in Great Britain: a national study, 1969–1993. Int J Cancer 2006,
118:2840–2846.
8. Committee on Medical Aspects of Radiation in the Environment (COMARE):
Eleventh report. The distribution of childhood leukaemia and other childhood
cancers in Great Britain 1969–1993. Chilton, Didcot, Oxfordshire: Health
Protection Agency, Radiation Protection Division; 2006.
9. Eyre R, Feltbower RG, Mubwandarikwa E, Eden TO, McNally RJ:
Epidemiology of bone tumours in children and young adults. Pediatr
Blood Cancer 2009, 53:941–952.
10. Savage SA, Mirabello L: Using epidemiology and genomics to understand
osteosarcoma etiology. Sarcoma 2011, 2011:548151.
11. Stiller CA, Allen MB, Eatock EM: Childhood cancer in Britain: the National
Registry of Childhood Tumours and incidence rates, 1978–1987. Eur J
Cancer 1995, 31A:2028–2034.
12. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S:
International Classification of Diseases for Oncology (ICD-O), 3rd ed. Geneva:
World Health Organization; 2000.
13. Office of Population Censuses and Surveys Census Division, General Register
Office (Scotland) Census Branch. 1981 Census: Digitised Boundary Data
(Great Britain), ESRC/JISC Census Programme, Edinburgh: University of
Edinburgh, Census Geography Data Unit (UKBORDERS); 1981.
14. Office for National Statistics: 1991 Census: Digitised Boundary Data (Great
Britain), ESRC/JISC Census Programme, University of Edinburgh, Census
Geography Data Unit (UKBORDERS). Edinburgh:; 1991.
McNally et al. BMC Cancer 2012, 12:270 Page 9 of 10
http://www.biomedcentral.com/1471-2407/12/270
15. Office for National Statistics: 2001 Census: Digitised Boundary Data (Great
Britain), ESRC/JISC Census Programme, University of Edinburgh, Census
Geography Data Unit (UKBORDERS). Edinburgh:; 2001.
16. Norman P, Simpson L, Sabater A: ‘Estimating with Confidence’ and
hindsight: new UK small-area population estimates for 1991. Popul Space
Place 2008, 14:449–472.
17. Office of Population Censuses and Surveys Census Division, General Register
Office (Scotland) Census Branch: 1981 Census Small Area Statistics: 100%
Population and Households Aggregated to Ward Level (Great Britain)
[computer file]. Colchester, Essex: UK Data Archive [distributor], SN; 1893.
18. Office for National Statistics: 1991 Census: Small Area Statistics and Local Base
Statistics [computer file]. University of Manchester, ESRC/JISC Census
Programme, Census Dissemination Unit.: ; 1991.
19. Office for National Statistics: 2001 Census: Small Area Statistics and Local Base
Statistics [computer file]. University of Manchester, ESRC/JISC Census
Programme, Census Dissemination Unit. Manchester:; 2001.
20. Townsend P, Phillimore P, Beattie A: Health and Deprivation: Inequality and
the North. Croom Helm: London; 1988.
21. Norman P: Identifying change over time in small area socio-economic
deprivation. Appl Spatial Anal Pol 2010, 3:107–138.
22. Bray F: Age-standardization. In Cancer Incidence in Five Continents, Volume
VIII. Edited by Parkin DM, Whelan SL, Gao YT, Ferlay J, Teppo L, Thomas DB.
Lyon, France: IARC Scientific Publications; 2002.
23. Segi M: Cancer mortality for selected sites in 24 countries (1950–57). Sendai,
Japan: Tohoku University School of Public Health; 1960.
24. Doll E, Payne P, Waterhouse J: Cancer Incidence in Five Continents: A
Technical Report. Berlin, Germany: Springer-Verlag (for UICC); 1966.
25. StataCorp: Stata Statistical Software: Release 10. College Station. TX:
StataCorp LP; 2007.
26. Richardson C, Montfort C: Ecological correlation studies. In Spatial
Epidemiology: Methods and Applications. Edited by Elliott P, Wakefield J, Best
N, Briggs D. Oxford: Oxford University Press; 2000.
27. Stiller CA: Epidemiology and genetics of childhood cancer. Oncogene
2004, 23:6429–6444.
28. Hwang SJ, Lozano G, Amos CI, Strong LC: Germline p53 mutations in a
cohort with childhood sarcoma: sex differences in cancer risk. Am J Hum
Genet 2003, 72:975–983.
29. Fletcher CD, Unni K, Mertens K: World Health Organization classification of
tumours: Pathology and genetics of tumours of soft tissue and bone. Lyon:
IARC Press; 2002.
30. Savage SA, Burdett L, Troisi R, Douglass C, Hoover RN, Chanock SJ: National
Osteosarcoma Etiology study group. Germ-line genetic variation in TP53
in osteosarcoma. Pediatr Blood Cancer 2007, 49:28–33.
31. Sandberg AA, Bridge JA: Updates on the cytogenetics and molecular
genetics of bone and soft tissue tumors: osteosarcoma and related
tumors. Cancer Genet Cytogenet 2003, 145:1–30.
32. Ladanyi M, Gorlick R: Molecular pathology and molecular pharmacology
of osteosarcoma. Pediatr Pathol Mol Med 2000, 19:391–413.
33. Patio-Garcia A, Sotillo-Pieiro E, Modesto C, Sierrases-Maga L: Analysis of the
human tumours necrosis factor-alpha (TNFalpha) gene promoter
polymorphisms in children with bone cancer. J Med Genet 2000, 37:789–
792.
34. Arora RS, Kontopantelis E, Alston RD, Eden TO, Geraci M, Birch JM:
Relationship between height at diagnosis and bone tumours in young
people: a meta-analysis. Cancer Causes Control 2011, 22:681–688.
35. Mirabello L, Pfeiffer R, Murphy G, Daw NC, Patino-Garcia A, Troisi RJ, Hoover
RN, Douglass C, Schuz J, Craft AW, Savage SA: Height at diagnosis and
birth-weight as risk factors for osteosarcoma. Caner Causes Control 2011,
22:899–908.
36. Arora RS, Alston RD, Eden TO, Geraci M, Birch JM: The contrasting age-
incidence patterns of bone tumours in teenagers and young adults:
implications for aetiology. Int J Cancer 2011, doi:10.1002/ijc.27402 [Epub
ahead of print].
37. Frentzel-Beyme R, Becher H, Salzer-Kuntschik M, Kotz R, Salzer M: Factors
affecting the incident juvenile bone tumors in an Austrian case–control
study. Cancer Detect Prev 2004, 28:159–169.
38. McNally RJ, Eden TO: An infectious aetiology for childhood acute
leukaemia: A review of the evidence. Br J Haematol 2004, 127:243–263.
39. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H,
Joubert I, de Jong P, Rouleau G, Aurias A, Thomas G: Gene fusion with an
ETS DNA-binding domain caused by chromosome translocation in
human tumours. Nature 1992, 359:162–165.
40. Ozaki T, Schaefer KL, Wai D, Yokoyama R, Ahrens S, Diallo R, Hasegawa T,
Shimoda T, Hirohashi S, Kawai A, Naito N, Morimoto Y, Inoue H, Boecker W,
Juergens H, Winkelmann W, Dockhorn-Dworniczak B, Poremba C:
Population-based genetic alterations in Ewing’s sarcoma from Japanese
and European Caucasian patients. Ann Oncol 2002, 13:1656–1664.
41. Holly EA, Aston DA, Ahn DK, Kristiansen JJ: Ewing’s bone sarcoma, paternal
occupational exposure, and other factors. Am J Epidemiol 1992, 135:122–129.
42. Moore LE, Gold L, Stewart PA, Gridley G, Prince JR, Zahm SH: Parental
occupational exposures and Ewing’s sarcoma. Int J Cancer 2005, 114:472–
478.
43. Valery PC, McWhirter W, Sleigh A, Williams G, Bain C: Farm exposures,
parental occupation, and risk of Ewing’s sarcoma in Australia: A national
case–control study. Cancer Causes Control 2002, 13:263–270.
doi:10.1186/1471-2407-12-270
Cite this article as: McNally et al.: Small-area analyses of bone cancer
diagnosed in Great Britain provide clues to aetiology. BMC Cancer 2012
12:270.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
McNally et al. BMC Cancer 2012, 12:270 Page 10 of 10
http://www.biomedcentral.com/1471-2407/12/270
